May 5, 2026
Here’s a pattern I’ve seen repeatedly. A medical affairs team builds a publication plan. Timelines align to a congress deadline. Authors are confirmed. A solid...
Read More
April 21, 2026
On March 30, 2026, I attended RISE Together: Data Sharing Across the Rare Disease Ecosystem [1] expecting a discussion about the platforms and infrastructure needed...
Read More
April 10, 2026
On March 25, 2026, I attended MAX: Medical Affairs eXcellence Forum, Canada’s first forum dedicated entirely to medical affairs in biopharma. Organized by Agilis Health...
Read More
March 24, 2026
In the first three articles of this series, we looked at AI where people can see it: reading scans and drafting treatment plans, tutoring students...
Read More
March 17, 2026
Traditional drug development is one of the most expensive and failure-prone endeavors in science. Bringing a new drug to market typically takes over a decade,...
Read More